Contineum Therapeutics (CTNM) EPS (Basic) (2023 - 2024)
Historic EPS (Basic) for Contineum Therapeutics (CTNM) over the last 2 years, with Q4 2024 value amounting to -$0.57.
- Contineum Therapeutics' EPS (Basic) fell 754.72% to -$0.57 in Q4 2024 from the same period last year, while for Sep 2025 it was -$0.52, marking a year-over-year increase of 6241.27%. This contributed to the annual value of -$2.18 for FY2024, which is 26029.41% down from last year.
- As of Q4 2024, Contineum Therapeutics' EPS (Basic) stood at -$0.57, which was down 754.72% from -$0.4 recorded in Q3 2024.
- Contineum Therapeutics' 5-year EPS (Basic) high stood at $2.56 for Q2 2023, and its period low was -$3.55 during Q1 2024.